Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Giuliani, M. [1 ]
Prosperini, L. [1 ]
Fanelli, F. [1 ]
Hirsch, M. N. [1 ]
De Angelis, F. [1 ,2 ]
Pozzilli, C. [1 ]
机构：
[1] Univ Roma La Sapienza, I-00185 Rome, Italy
[2] UCL, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P633
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [1] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [2] Pharmacogenomic predictors of fingolimod response in relapsing-remitting multiple sclerosis
    Campagna, M. P.
    Stankovich, J.
    Zhong, M.
    Kleinova, P.
    Matesanz, F.
    Eichau, S.
    Slee, M.
    Kilpatrick, T.
    Kubala Havrdova, E.
    Izquierdo, G.
    Patsopoulos, N.
    Lea, R.
    Lechner-Scott, J.
    Butzkueven, H.
    Jokubaitis, V.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 660 - 661
  • [3] Oral fingolimod for relapsing-remitting multiple sclerosis
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1777 - 1781
  • [4] Effects of fingolimod in relapsing-remitting multiple sclerosis Comment
    Sorensen, Per Soelberg
    [J]. LANCET NEUROLOGY, 2014, 13 (06): : 526 - 527
  • [5] ORAL FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Vosiliou, S.
    [J]. DRUGS OF TODAY, 2010, 46 (05) : 315 - 325
  • [6] Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis
    Derfuss, T.
    Bergvall, N. K.
    Sfikas, N.
    Tomic, D. L.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (09) : 1687 - 1691
  • [7] Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
    Yavari, Fatemeh
    Oliazadeh, Pardis
    Radfar, Meisam
    Foroughipour, Mohsen
    Nikkhah, Karim
    Bakavoli, Alireza Heidari
    Saeidi, Morteza
    [J]. BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (02) : 233 - 242
  • [8] The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis
    Kotov, S. V.
    Fedorova, S. I.
    Yakushina, T. I.
    Lizhdvoy, V. Yu
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (02) : 74 - 78
  • [9] Predicting the response status to natalizumab in relapsing-remitting multiple sclerosis
    Prosperini, L.
    Mancinelli, C. R.
    Gianni, C.
    Barletta, V.
    Fubelli, F.
    Borriello, G.
    Pozzilli, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 469 - 470
  • [10] Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis
    Mark Sanford
    [J]. Drugs, 2014, 74 : 1411 - 1433
12345